The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Nonfiction, Health & Well Being, Psychology, Psychiatry, Medical, Specialties
Cover of the book The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder by American Psychiatric Association, American Psychiatric Association Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: American Psychiatric Association ISBN: 9780890426838
Publisher: American Psychiatric Association Publishing Publication: January 11, 2018
Imprint: American Psychiatric Association Language: English
Author: American Psychiatric Association
ISBN: 9780890426838
Publisher: American Psychiatric Association Publishing
Publication: January 11, 2018
Imprint: American Psychiatric Association
Language: English

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.

More books from Specialties

Cover of the book Mechanics of Breathing by American Psychiatric Association
Cover of the book Epithelial Abnormalities of the Cervix Uteri by American Psychiatric Association
Cover of the book Vasculitis in Clinical Practice by American Psychiatric Association
Cover of the book Therapeutic Gastrointestinal Endoscopy by American Psychiatric Association
Cover of the book Neoplastic Mimics in Thoracic and Cardiovascular Pathology by American Psychiatric Association
Cover of the book Atlas of Retinal OCT E-Book by American Psychiatric Association
Cover of the book The SAGES Manual by American Psychiatric Association
Cover of the book The Analysis of Drugs in Biological Fluids by American Psychiatric Association
Cover of the book Atlas of Neuroanatomy for Communication Science and Disorders by American Psychiatric Association
Cover of the book Practical Skin Pathology: A Diagnostic Approach E-Book by American Psychiatric Association
Cover of the book Alternative and Complementary Therapies for Children with Psychiatric Disorders, An Issue of Child and Adolescent Psychiatric Clinics of North America, E-Book by American Psychiatric Association
Cover of the book Psychiatric Care in Severe Obesity by American Psychiatric Association
Cover of the book Cancer Research and Clinical Trials in Developing Countries by American Psychiatric Association
Cover of the book Endoscopy of the Upper GI Tract by American Psychiatric Association
Cover of the book Near Misses in Pediatric Anesthesia by American Psychiatric Association
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy